InspireMD disclosed today that Craig Shore, the company’s Chief Financial Officer, has chosen to retire once his successor is identified and appointed. Shore plans to maintain his role as CFO until the stroke prevention firm selects his replacement, ensuring a seamless handover. Over his 15-year tenure at InspireMD, Shore played a pivotal role in establishing the company as “a global leader in carotid interventions,” according to CEO Marvin Slosman.
“It has been a privilege to aid InspireMD in evolving from an emerging growth enterprise into a distinguished leader in carotid intervention and stroke prevention,” Shore remarked. “The future holds exciting prospects for the company as it expands, and I am confident in the path ahead. While I anticipate my personal new chapter, I am proud of my contributions to this notable journey.”
Headquartered in Miami, InspireMD has already begun searching for its new CFO.
“As we progress with our objectives, including the prospective U.S. FDA approval projected for the first half of 2025, and enhance our engagement with the investment community, Craig made this move with trust in the company’s future and an understanding of the demands of a burgeoning global enterprise,” Slosman stated. “I extend gratitude on behalf of the entire InspireMD team and board of directors for Craig’s invaluable input over the past 15 years. Having had the pleasure to collaborate with him over the past five years, I am delighted that he will remain with us through this critical transition period.”